Blood-thinning drug Pradaxa is linked to 117 US deaths
A blood-thinning drug which is costing the HSE up to 100 times more than the leading alternative may have been responsible for more than 100 deaths in the United States.
A blood-thinning drug which is costing the Health Service Executive (HSE) up to 100 times more than the leading alternative may have been responsible for more than 100 deaths in the United States in three months last year, according to a new report.
The US Food and Drug Administration (FDA) said that Pradaxa (or dabigatran) had been linked to at least 117 deaths in the second quarter of 2011.
Pradaxa, an anticoagulant, had been on the market for less...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine